|
How to Advertise on Betterchem.com…
Most advertising on this site is managed by Google Adwords. Adwords lets businesses advertise on sites
regardless of their budget. At Betterchem, your Ad campaigns can target keywords and/or the visitor's
geographical location. We do not participate in Adwords targeted campaigns at this time.
|
|
|
|
|
If you would like to target one or more of our network's 200,000 plus pages…
Purchase a banner space for a low monthly fee. Banner spaces on individual pages are available for as little as $50/month. Email sales@betterchem.com. Place "Banner Placement" in the subject line and include our page's URL (where you'd like your banner to appear) in the subject. You need to supply us with links to your banner image and URL for the target page (at your site). We will revert with price and conditions. Betterchem reserves the right to refuse ads that do not meet our editorial standards.
|
|
Free
Ad space for your pharma products.
Simply list your products and create a reciprocal link. See how.
|
| Keywords for the Ads: Tequin (Gatifloxacin) Tablets, Injection & Dextrose Injection, Bristol-Myers Squibb NDA 21-061/S11, 21-061/S15 & 21-062/S15 12/19/02 1/29/03 4/7/03
Tequin (Gatifloxacin) Tablets & Injection, Bristol-Myers Squibb NDA 21-061/S8/S9/S12
10/31/01 05/08/03
Tequin (Gatifloxacin) Tablets & Injection, Bristol-Myers Squibb NDA 21-061/S7
NDA 21-062/S8 10/12/01 6/19/02 6/19/02 6/19/02
Tequin (Gatifloxacin) Tablets & Injection, Bristol-Myers Squibb NDA 21-062/S9/S10/S12 10/31/01 05/8/03
Tequin (Gatifloxacin) Tablets & Injection, Bristol-Myers Squibb NDA 21-062/S6/S7 08/20/01 05/08/03
Tequin (Gatifloxacin) Tablets & Injection, Bristol-Myers Squibb NDA 21-061/S5/S6
08/20/01 05/08/03
Tequin (Gatifloxacin) Tablets & Injection, Bristol-Myers Squibb NDA 21-404, 21-405, 21-061/S-010, 21-062/S-011, 21-061/S-016 & 21-062/S-017 10/17/02 10/21/02 10/18/02
Tequin (Gatifloxacin) Tablets & IV, 200 and 400mg / IV-10mg/mL vials and 2mg/mL flexible containers, Bristol-Myers Squibb NDA 21-061
NDA 21-062 12/17/99 12/27/99 12/27/99 7/18/01
Tequin (Gatifloxacin) Indications: 1. Acute Bacterial Sinusitis, 2. Community Acquired Pneumonia, 3. Acute Bacterial Exacerbation Chronic Bronchitis, 4. Uncomplicated Urinary Tract Infections, 5. Complicated Urinary Tract Infections, 6. Pyelonephritis, 7. Uncomplicated Gonorrhea Zymar (gatifloxacin) ophthalmic solution, 0.3% Allergan, NDA 21-493 GATIFLOXACIN Injection 10MG /ML(200MG) TEQUIN BRISTOL MYERS SQUIBB
021062 GATIFLOXACIN Injection 10MG /ML(400MG) TEQUIN BRISTOL MYERS SQUIBB
021062 GATIFLOXACIN Injection 2MG /ML(200MG/100ML) TEQUIN BRISTOL MYERS SQUIBB
021062 GATIFLOXACIN Injection 2MG /ML(400MG/200ML) TEQUIN BRISTOL MYERS SQUIBB
021493 GATIFLOXACIN Solution/Drops; Ophthalmic 0.3% ZYMAR ALLERGAN
021061 GATIFLOXACIN Tablet; 200MG TEQUIN BRISTOL MYERS SQUIBB
021061 GATIFLOXACIN Tablet; 400MG TEQUIN BRISTOL MYERS SQUIBB
© 2008 Betterchem Corp.
|
|
